Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1586/14760584.2014.938056 http://scihub22266oqcxt.onion/10.1586/14760584.2014.938056 C4331125!4331125 !25017952     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=25017952 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Expert+Rev+Vaccines 2014 ; 13 (11 ): 1271-3 Nephropedia Template TP {{tp|p=25017952 |t=2014. Will studies in individuals with systemic lupus erythematosus be the key to future HIV vaccine design? |pdf=|usr=}}{{25017952 }} gab.com Text Will studies in individuals with systemic lupus erythematosus be the key to future HIV vaccine design JO: Expert Rev Vaccines http://www.kidney.de/pget.php?&tw=1&pmid=25017952 #FOAvip The induction of HIV-1 broadly neutralizing antibodies (bnAbs) remains the primary goal of a preventive HIV-1 vaccine but no HIV-1 vaccine candidate has succeeded in inducing bnAbs. All the bnAbs isolated from chronically HIV-1 infected subjects display one or more traits associated with control by host tolerance and immunoregulatory mechanisms, including reactivity against self antigens. Recent studies on a HIV-1 patient with concurrent systemic lupus erythematosus have informed on how similar bnAbs are to typical autoantibodies controlled by immune tolerance mechanisms. Future studies aimed at elucidating the intersection between autoantibodies generated in the context of systemic lupus erythematosus and the development of HIV-1 bnAbs will further our knowledge of specific roadblocks that hamper the production of bnAbs and, ultimately, inform us on how to implement vaccine strategies to circumvent them. Twit Text FOAVip Will studies in individuals with systemic lupus erythematosus be the key to future HIV vaccine design ????Expert Rev Vaccines http://www.kidney.de/pget.php?&tw=1&pmid=25017952 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25017952 #FOAvip English Wikipedia <ref>{{Cite pmid|25017952 }}</ref> Will studies in individuals with systemic lupus erythematosus be the key to future HIV vaccine design? #MMPMID25017952 Bonsignori M Expert Rev Vaccines 2014[Nov]; 13 (11 ): 1271-3 PMID25017952 show ga The induction of HIV-1 broadly neutralizing antibodies (bnAbs) remains the primary goal of a preventive HIV-1 vaccine but no HIV-1 vaccine candidate has succeeded in inducing bnAbs. All the bnAbs isolated from chronically HIV-1 infected subjects display one or more traits associated with control by host tolerance and immunoregulatory mechanisms, including reactivity against self antigens. Recent studies on a HIV-1 patient with concurrent systemic lupus erythematosus have informed on how similar bnAbs are to typical autoantibodies controlled by immune tolerance mechanisms. Future studies aimed at elucidating the intersection between autoantibodies generated in the context of systemic lupus erythematosus and the development of HIV-1 bnAbs will further our knowledge of specific roadblocks that hamper the production of bnAbs and, ultimately, inform us on how to implement vaccine strategies to circumvent them. |AIDS Vaccines/*immunology/*isolation & purification [MESH] |Antibodies, Neutralizing/blood [MESH] |Autoantibodies/*blood [MESH] |HIV Antibodies/*blood [MESH] |HIV Infections/*prevention & control [MESH] |HIV-1/*immunology [MESH] |Humans [MESH] |Immune Tolerance [MESH]Will studies in individuals with systemic lupus erythematosus be the k(epmc).pdf DeepDyve Pubget Overpricing